BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

  December 13, 2024

   · 

  2 min read
• Press Releases

  Incyclix Bio Announces Interim Clinical Data from the Phase 1/2 Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors

  December 13, 2024

   · 

  3 min read
• Press Releases

  Biotech Nintx Raises US$ 10 Million to Advance a New Generation of Medicines Based on Brazilian Biodiversity

  December 13, 2024

   · 

  3 min read
• Press Releases

  Amarin Appoints Peter Fishman Chief Financial Officer

  December 13, 2024

   · 

  4 min read
• Press Releases

  Roche Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for TECENTRIQ SC (atezolizumab, solution for subcutaneous injection)

  December 13, 2024

   · 

  3 min read
• Press Releases

  100% of Patients Achieve Remission Within 30 Days in Cohort 1 of Bispecific Mipletamig Frontline AML Trial

  December 13, 2024

   · 

  9 min read
• Press Releases

  Candel Therapeutics Announces $80 Million Proposed Public Offering

  December 13, 2024

   · 

  5 min read
• Press Releases

  CENTENE CORPORATION ANNOUNCES 2025 GUIDANCE

  December 13, 2024

   · 

  12 min read
• Press Releases

  Novellia Data Shown to Optimize Risk Profiling to Inform HER2+ Breast Cancer Care

  December 13, 2024

   · 

  5 min read
• Press Releases

  Keros Therapeutics Announces Update on the Phase 2 TROPOS Trial

  December 13, 2024

   · 

  5 min read